20 alpha-dihydrodidrogesterone single crystal as well as preparation method and application thereof
Through the method of slow volatilization in ethanol and liquid chromatography separation, 20α-dihydrodedrone single crystal was prepared and confirmed, which solved the problem that the prior art could not confirm its three-dimensional structure and provided an important part of drug research data.
Patent Information
- Application Number
- CN202410864153.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-04-30
- Filing Date
- 2024-06-30
- Publication Date
- 2024-11-15
AI Technical Summary
The prior art cannot confirm the absolute configuration of 20α-dihydrodeddrogesterone, and its single crystal and its preparation method have not been reported, making it difficult to confirm the three-dimensional structure.
By dissolving 20α-dihydrodeddrogenone in ethanol, slowly evaporating, combined with dedrogenone and sodium borohydride, liquid chromatography was performed to prepare 20α-dihydrodeddrogenone single crystals and pass through single Crystal X-ray diffraction method confirms its three-dimensional configuration.
The 20α-dihydrodeddrogesterone single crystal was successfully prepared to confirm its three-dimensional configuration, providing important data for drug research, and solving the problem that the prior art cannot confirm the absolute configuration.
Smart Images

Figure CN118955597A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of 20α-dihydrodydrogesterone crystals, and specifically relates to a 20α-dihydrodydrogesterone single crystal and a preparation method and application thereof. Background Art
[0002] Dydrogesterone, whose chemical name is 9β,10α-pregnane-4,6-diene-3,20-dione, can be used to treat diseases caused by endogenous progesterone deficiency, such as dysmenorrhea, endometriosis, secondary amenorrhea, irregular menstrual cycle, dysfunctional uterine bleeding, premenstrual syndrome, threatened abortion or habitual abortion caused by progesterone deficiency, and infertility caused by corpus luteum deficiency.
[0003] 20α-Dihydrodydrogesterone is the main active metabolite of dydrogesterone in the human body. 20α-Dihydrodydrogesterone, chemical name is 20α-hydroxy-9β,10α-pregnane-4,6-diene-3-one, molecular formula is C 21 H 30 O2, the chemical structure is shown below.
[0004]
[0005] As far as the inventors know, the absolute configuration of the currently commercially available 20α-dihydrodydrogesterone cannot be confirmed. Single crystal X-ray diffraction is the preferred method for confirming the absolute configuration, but it is necessary to prepare single crystals of the compound to be tested for testing. However, the Cambridge Crystal Data Center (CCDC) does not include single crystal data of 20α-dihydrodydrogesterone, and the prior art does not report 20α-dihydrodydrogesterone single crystals and their preparation methods.
[0006] Therefore, how to prepare a single crystal of 20α-dihydrodydrogesterone for use in stereostructure confirmation is an unsolved technical problem in the field. Summary of the invention
[0007] The technical problem to be solved by the present invention is to provide a 20α-dihydrodydrogesterone single crystal and a preparation method thereof, which can be used for confirming the stereostructure of 20α-dihydrodydrogesterone.
[0008] The technical problem of the present invention is solved by the following technical solutions:
[0009] In one aspect, the present invention provides a 20α-dihydrodydrogesterone single crystal, which is a monoclinic crystal system, and its crystal axis The angles between the crystal planes are α=90°, β=105.114°, and γ=90°.
[0010] Preferably, the unit lattice area The number of molecules in the unit cell is Z = 2, and the density is d = 1.195 g / cm3 .
[0011] On the other hand, the present invention provides a method for preparing a 20α-dihydrodydrogesterone single crystal, comprising dissolving 20α-dihydrodydrogesterone in ethanol, slowly volatilizing, and precipitating a 20α-dihydrodydrogesterone single crystal.
[0012] Preferably, the purity of 20α-dihydrodydrogesterone is >95%.
[0013] Preferably, the concentration of 20α-dihydrodydrogesterone in ethanol is 0.5-3%.
[0014] More preferably, the concentration of 20α-dihydrodydrogesterone in ethanol is 1%
[0015] Preferably, the crystallization temperature is 15-35°C.
[0016] More preferably, the crystallization temperature is 20°C.
[0017] Preferably, the crystallization time is 3 to 15 days.
[0018] More preferably, the crystallization time is 7 days.
[0019] Preferably, the preparation method further comprises:
[0020] 1) dissolving dydrogesterone in methanol, adding sodium borohydride, and after the reaction is complete, adding water to quench, and removing the solvent by vacuum rotary evaporation to obtain a crude product of 20α-dihydrodydrogesterone;
[0021] 2) The crude product was separated and purified by preparative liquid chromatography to obtain pure 20α-dihydrodydrogesterone.
[0022] More preferably, in step 1), the concentration of dydrogesterone in methanol is 5-15%.
[0023] More preferably, in step 1), the molar ratio of dydrogesterone to sodium borohydride is 1:(5-15).
[0024] More preferably, the reaction temperature in step 1) is 0-30°C.
[0025] More preferably, in step 2), the chromatographic column is filled with octadecylsilane bonded silica gel.
[0026] Most preferably, the chromatographic column in step 2) is XBridge C18, Ulitmate AQ-C18, Xtimate C18, SunFire C18 OBD or a chromatographic column with equivalent performance.
[0027] More preferably, in step 2), mobile phase A is trifluoroacetic acid aqueous solution; mobile phase B is methanol and / or ethanol.
[0028] Most preferably, in step 2), mobile phase A is 0.05% trifluoroacetic acid aqueous solution; mobile phase B is 50% methanol and 50% ethanol.
[0029] More preferably, in step 2), the elution is performed according to the following gradient:
[0030]
[0031] Most preferably, in step 2), the elution is performed according to the following gradient:
[0032]
[0033] More preferably, the flow rate in step 2) is 13-25 ml / min.
[0034] More preferably, in step 2), the column temperature is room temperature.
[0035] More preferably, the detection wavelength in step 2) is 210-254 nm.
[0036] In yet another aspect, the present invention provides a use of a 20α-dihydrodydrogesterone single crystal in confirming the stereo configuration of 20α-dihydrodydrogesterone.
[0037] The 20α-dihydrodydrogesterone single crystal and its preparation method and application of the present invention have the following beneficial effects compared with the prior art:
[0038] 1) It is difficult to obtain 20α-dihydrodydrogesterone single crystal by the recrystallization method in the prior art. The present invention obtains 20α-dihydrodydrogesterone single crystal by a slow volatilization method in which ethanol is preferably used as the crystallization solvent.
[0039] 2) The present invention confirms the stereo configuration of 20α-dihydrodydrogesterone by single crystal X-ray diffraction. In the obtained stereo configuration diagram, the -OH on the chiral carbon of C20 points in the same direction as the -CH3 on the chiral carbon of C13, and points in the opposite direction to the -CH3 on the chiral carbon of C10. Therefore, the stereo configuration of 20α-dihydrodydrogesterone is confirmed as follows, wherein the absolute configuration of C20 is α configuration.
[0040] BRIEF DESCRIPTION OF THE DRAWINGS
[0041] Figure 1 This is the liquid phase test result of the crude 20α-dihydrodydrogesterone of Example 1;
[0042] Figure 2 This is the liquid phase test result of the pure 20α-dihydrodydrogesterone of Example 1;
[0043] Figure 3 is the 20α-dihydrodydrogesterone of Example 1 1HNMR test results;
[0044] Figure 4 The differential scanning calorimetry test result of the 20α-dihydrodydrogesterone single crystal of Example 2;
[0045] Figure 5 This is a molecular stereo configuration diagram of the 20α-dihydrodydrogesterone single crystal of Example 2. DETAILED DESCRIPTION
[0046] The technical solution of the present invention is further described below in conjunction with the embodiments. However, the protection scope of the present invention includes but is not limited to these embodiments, and any changes or equivalent substitutions that do not deviate from the concept of the present invention are included in the protection scope of the present invention.
[0047] The instruments and reagents used in the examples of the present invention are all commercially available products. The source of 20α-dihydrodydrogesterone is not particularly limited and can be prepared by oneself or obtained from the market.
[0048] Example 1 Preparation of 20α-dihydrodydrogesterone
[0049] Weigh 1.0 g of dydrogesterone and dissolve it in 10 mL of methanol. Keep the mixture at 0-25° C. and add 1.21 g of sodium borohydride in batches. After reacting for 1-2 hours, take samples and send them for liquid chromatography-mass spectrometry detection. If the raw material reacts completely, add water to quench the reaction, and remove the solvent by vacuum rotary evaporation to obtain a crude product.
[0050]
[0051] The liquid phase test results are as follows Figure 1 As shown, the apparent purity of 20α-dihydrodydrogesterone (retention time 15.477 min) in the liquid phase is 5.27%, and the apparent purity of the isomer 20β-dihydrodydrogesterone (retention time 22.011 min) in the liquid phase is 40.46%, and other impurities are also contained.
[0052] The crude product was dissolved in the mobile phase and separated and purified by preparative liquid chromatography. The separation conditions were as follows: chromatographic column: octadecylsilane bonded silica gel as filler (21.2 mm × 250 mm × 5 μm) or a chromatographic column with equivalent performance; column temperature: room temperature;
[0053] Wavelength: 254nm; Flow rate: 13-25ml / min; Mobile phase: Mobile phase A is 0.05% trifluoroacetic acid aqueous solution; Mobile phase B is 50% methanol and 50% ethanol, eluted according to the following gradient:
[0054]
[0055] The components with elution time of 15 to 16.2 min were collected and distilled under reduced pressure to obtain 250 mg of pure product.
[0056] The results of the liquid phase test of the pure product are as follows Figure 2 As shown, the purity is 96.81%; 1 The results of HNMR test are as follows Figure 3 As shown, the structure of 20-dihydrodydrogesterone was confirmed.
[0057] Example 2 Preparation of 20α-dihydrodydrogesterone single crystal
[0058] Weigh 10 mg of pure 20α-dihydrodydrogesterone, dissolve it in 1 mL of ethanol, and place it in a dark environment at 20°C to slowly evaporate for 7 days to obtain colorless block crystals.
[0059] The obtained crystals were subjected to differential scanning calorimetry. The test results were as follows: Figure 4 As shown, the melting point was found to be 170.18°C.
[0060] The obtained crystal was subjected to a single crystal X-ray diffraction test. The crystal belongs to the monoclinic system, and the unit cell parameters are shown in Table 1 below:
[0061]
[0062]
[0063] The spatial structure of a single crystal is shown in the figure Figure 5 As shown, the -OH on the chiral carbon of C20 (C18 in the figure) points in the same direction as the -CH3 on the chiral carbon of C13 (C13 in the figure), and points in the opposite direction to the -CH3 on the chiral carbon of C10 (C4 in the figure). Therefore, the stereo configuration of 20α-dihydrodydrogesterone is confirmed as follows, wherein the absolute configuration of C20 is α configuration.
[0064]
[0065] Example 3-12 Investigation of crystallization conditions
[0066] On the basis of Example 2, the effects of the type and amount of crystallization solvent, crystallization temperature and crystallization time on the preparation of 20α-dihydrodydrogesterone single crystal were investigated.
[0067] The differences and results from Example 2 are shown in Table 2:
[0068] Example Crystallization solvent Crystallization temperature Crystallization time Crystallization Example 3 1 mL methanol 20℃ 7 days White powder Example 4 1 mL dichloromethane 20℃ 7 days White powder Example 5 1mL dioxane 20℃ 7 days White powder Example 6 1mL tetrahydrofuran 20℃ 7 days White powder Example 7 1 mL ethyl acetate 20℃ 7 days White powder Example 8 0.5 mL ethyl acetate and 0.5 mL petroleum ether 20℃ 7 days White powder Example 9 0.5 mL methanol and 0.5 mL dichloromethane 20℃ 7 days White powder Example 10 0.5 mL methanol and 0.5 mL water 20℃ 7 days White powder Embodiment 11 2ml ethanol 15℃ 15 days Colorless block crystals Example 12 0.35 ml ethanol 35℃ 3 days Colorless block crystals
[0069] The results show that in the investigation of crystallization solvent types, in crystallization solvents such as methanol, dichloromethane, dioxane, tetrahydrofuran, ethyl acetate, ethyl acetate: petroleum ether = 1:1, methanol: dichloromethane = 1:1, methanol: water = 1:1, the products obtained after slow evaporation are all white powders, and no single crystals are formed under microscopic observation; when only ethanol is used as the crystallization solvent, single crystals can be precipitated.
[0070] On the basis that the crystallization solvent is ethanol, the preferred amount of ethanol is 0.35-2 ml, the crystallization temperature is 15-35° C., and the crystallization time is 3-15 days (Example 2 and Examples 11-12), and single crystals can be precipitated.
[0071] Comparative Example 1 Preparation of 20α-dihydrodydrogesterone
[0072] 10 mg of crude 20α-dihydrodydrogesterone was weighed and dissolved in 1 mL of acetone. The mixture was heated to dissolve and then slowly cooled to precipitate white powder. No single crystal was formed under microscope.
Claims
1. A 20α-dihydrodydrogesterone single crystal, characterized in that: It is a monoclinic system, with its crystal axis The angles between the crystal planes are α=90°, β=105.114°, and γ=90°.
2. The 20α-dihydrodydrogesterone single crystal according to claim 1, characterized in that Unit cell area The number of molecules in the unit cell is Z = 2, and the density is d = 1.195 g / cm 3 .
3. A method for preparing a 20α-dihydrodydrogesterone single crystal, characterized in that: The method comprises dissolving 20α-dihydrodydrogesterone in ethanol, slowly volatilizing the ethanol, and precipitating a 20α-dihydrodydrogesterone single crystal.
4. The method for preparing a 20α-dihydrodydrogesterone single crystal according to claim 3, characterized in that: The purity of the 20α-dihydrodydrogesterone is >95%; preferably, the concentration of the 20α-dihydrodydrogesterone in ethanol is 0.5-3%; preferably, the crystallization temperature is 15-35° C.; preferably, the crystallization time is 3-15 days.
5. The method for preparing a 20α-dihydrodydrogesterone single crystal according to claim 3, characterized in that: The preparation method further comprises: 1) dissolving dydrogesterone in methanol, adding sodium borohydride, and after the reaction is complete, adding water to quench, and removing the solvent by vacuum rotary evaporation to obtain a crude product of 20α-dihydrodydrogesterone; 2) The crude product was separated and purified by preparative liquid chromatography to obtain pure 20α-dihydrodydrogesterone.
6. The method for preparing a 20α-dihydrodydrogesterone single crystal according to claim 5, characterized in that: In the step 1), the concentration of dydrogesterone in methanol is 5-15%; preferably, the molar ratio of dydrogesterone to sodium borohydride is 1:(5-15); preferably, the reaction temperature is 0-30°C.
7. The method for preparing a 20α-dihydrodydrogesterone single crystal according to claim 5, characterized in that: In the step 2), the chromatographic column uses octadecylsilane bonded silica gel as a filler.
8. The method for preparing a 20α-dihydrodydrogesterone single crystal according to claim 5, characterized in that: In the step 2), mobile phase A is trifluoroacetic acid aqueous solution; mobile phase B is methanol and / or ethanol.
9. The method for preparing a 20α-dihydrodydrogesterone single crystal according to claim 5, characterized in that: In the step 2), the gradient elution is as follows: 。 10. Application of a 20α-dihydrodydrogesterone single crystal in confirming the stereo configuration of 20α-dihydrodydrogesterone.
Citation Information
Patent Citations
10alpha methyl, 9beta hormonal steroids
US3198792A
Novel c11 modified retrosteroids as progesterone receptor modulator compounds
WO2008113851A2
